Top compounds associated with response to TBL1Y


Feature Type Standardized
Nominal ANOVA
mRNA C6-ceramide CTRPv2 pan-cancer AAC -0.014 0.7
mRNA salermide:PLX-4032 (12:1 mol/mol) CTRPv2 pan-cancer AAC -0.014 0.7
mRNA Bortezomib FIMM pan-cancer AAC -0.07 0.7
mRNA SNX-2112 CTRPv2 pan-cancer AAC 0.012 0.7
mRNA masitinib CTRPv2 pan-cancer AAC -0.013 0.7
mRNA Docetaxel gCSI pan-cancer AAC -0.02 0.7
mRNA Crizotinib FIMM pan-cancer AAC -0.082 0.7
mRNA XAV-939 GDSC1000 pan-cancer AAC 0.012 0.7
mRNA AT13387 CTRPv2 pan-cancer AAC 0.017 0.7
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.013 0.7
Download CSV